Current Treatment Options in Oncology

Papers
(The H4-Index of Current Treatment Options in Oncology is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Role of Metastasis-Directed Therapy in Genitourinary Cancers123
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead91
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer86
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies81
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect67
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia60
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer60
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma57
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes56
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)50
Small Cell Lung Cancer—An Update on Chemotherapy Resistance48
An Update on Temporal Bone Paragangliomas48
Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T44
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?42
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?39
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors39
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers38
The Role of Nursing in the Delivery of Cardio-Oncology37
Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer36
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma34
Approach to Localized Squamous Cell Cancer of the Esophagus33
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities32
Management of Fatigue in Patients with Advanced Cancer32
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements31
Regorafenib for the Treatment of Sarcoma31
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?30
Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations30
Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management28
0.39475297927856